These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 24198383)

  • 1. Novel C12orf65 mutations in patients with axonal neuropathy and optic atrophy.
    Tucci A; Liu YT; Preza E; Pitceathly RD; Chalasani A; Plagnol V; Land JM; Trabzuni D; Ryten M; ; Jaunmuktane Z; Reilly MM; Brandner S; Hargreaves I; Hardy J; Singleton AB; Abramov AY; Houlden H
    J Neurol Neurosurg Psychiatry; 2014 May; 85(5):486-92. PubMed ID: 24198383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delineation of C12orf65-related phenotypes: a genotype-phenotype relationship.
    Spiegel R; Mandel H; Saada A; Lerer I; Burger A; Shaag A; Shalev SA; Jabaly-Habib H; Goldsher D; Gomori JM; Lossos A; Elpeleg O; Meiner V
    Eur J Hum Genet; 2014 Aug; 22(8):1019-25. PubMed ID: 24424123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A homozygous mutation of C12orf65 causes spastic paraplegia with optic atrophy and neuropathy (SPG55).
    Shimazaki H; Takiyama Y; Ishiura H; Sakai C; Matsushima Y; Hatakeyama H; Honda J; Sakoe K; Naoi T; Namekawa M; Fukuda Y; Takahashi Y; Goto J; Tsuji S; Goto Y; Nakano I;
    J Med Genet; 2012 Dec; 49(12):777-84. PubMed ID: 23188110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compound Heterozygote Mutation of
    Fang XJ; Zhang W; Lyu H; Wang ZX; Wang WW; Yuan Y
    Chin Med J (Engl); 2017 Jan; 130(2):242-244. PubMed ID: 28091420
    [No Abstract]   [Full Text] [Related]  

  • 5. Axonal neuropathy with optic atrophy is caused by mutations in mitofusin 2.
    Züchner S; De Jonghe P; Jordanova A; Claeys KG; Guergueltcheva V; Cherninkova S; Hamilton SR; Van Stavern G; Krajewski KM; Stajich J; Tournev I; Verhoeven K; Langerhorst CT; de Visser M; Baas F; Bird T; Timmerman V; Shy M; Vance JM
    Ann Neurol; 2006 Feb; 59(2):276-81. PubMed ID: 16437557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular genetics of inherited neuropathies].
    Takashima H
    Rinsho Shinkeigaku; 2006 Jan; 46(1):1-18. PubMed ID: 16541790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial dynamics and inherited peripheral nerve diseases.
    Pareyson D; Saveri P; Sagnelli A; Piscosquito G
    Neurosci Lett; 2015 Jun; 596():66-77. PubMed ID: 25847151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and genetic diversities of Charcot-Marie-Tooth disease with MFN2 mutations in a large case study.
    Ando M; Hashiguchi A; Okamoto Y; Yoshimura A; Hiramatsu Y; Yuan J; Higuchi Y; Mitsui J; Ishiura H; Umemura A; Maruyama K; Matsushige T; Morishita S; Nakagawa M; Tsuji S; Takashima H
    J Peripher Nerv Syst; 2017 Sep; 22(3):191-199. PubMed ID: 28660751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations.
    Chung KW; Kim SB; Park KD; Choi KG; Lee JH; Eun HW; Suh JS; Hwang JH; Kim WK; Seo BC; Kim SH; Son IH; Kim SM; Sunwoo IN; Choi BO
    Brain; 2006 Aug; 129(Pt 8):2103-18. PubMed ID: 16835246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and allelic heterogeneity in a pediatric cohort of 11 patients carrying MFN2 mutation.
    Di Meglio C; Bonello-Palot N; Boulay C; Milh M; Ovaert C; Levy N; Chabrol B
    Brain Dev; 2016 May; 38(5):498-506. PubMed ID: 26686600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational mechanisms in MFN2-related neuropathy: compound heterozygosity for recessive and semidominant mutations.
    Piscosquito G; Saveri P; Magri S; Ciano C; Di Bella D; Milani M; Taroni F; Pareyson D
    J Peripher Nerv Syst; 2015 Dec; 20(4):380-6. PubMed ID: 26306937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic epidemiology of Charcot-Marie-Tooth disease.
    Braathen GJ
    Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in COA7 cause spinocerebellar ataxia with axonal neuropathy.
    Higuchi Y; Okunushi R; Hara T; Hashiguchi A; Yuan J; Yoshimura A; Murayama K; Ohtake A; Ando M; Hiramatsu Y; Ishihara S; Tanabe H; Okamoto Y; Matsuura E; Ueda T; Toda T; Yamashita S; Yamada K; Koide T; Yaguchi H; Mitsui J; Ishiura H; Yoshimura J; Doi K; Morishita S; Sato K; Nakagawa M; Yamaguchi M; Tsuji S; Takashima H
    Brain; 2018 Jun; 141(6):1622-1636. PubMed ID: 29718187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic dysfunction of MT-ATP6 causes axonal Charcot-Marie-Tooth disease.
    Pitceathly RD; Murphy SM; Cottenie E; Chalasani A; Sweeney MG; Woodward C; Mudanohwo EE; Hargreaves I; Heales S; Land J; Holton JL; Houlden H; Blake J; Champion M; Flinter F; Robb SA; Page R; Rose M; Palace J; Crowe C; Longman C; Lunn MP; Rahman S; Reilly MM; Hanna MG
    Neurology; 2012 Sep; 79(11):1145-54. PubMed ID: 22933740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Charcot-Marie-Tooth disease type 2A: from typical to rare phenotypic and genotypic features.
    Bombelli F; Stojkovic T; Dubourg O; Echaniz-Laguna A; Tardieu S; Larcher K; Amati-Bonneau P; Latour P; Vignal O; Cazeneuve C; Brice A; Leguern E
    JAMA Neurol; 2014 Aug; 71(8):1036-42. PubMed ID: 24957169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ALS5/SPG11/KIAA1840 mutations cause autosomal recessive axonal Charcot-Marie-Tooth disease.
    Montecchiani C; Pedace L; Lo Giudice T; Casella A; Mearini M; Gaudiello F; Pedroso JL; Terracciano C; Caltagirone C; Massa R; St George-Hyslop PH; Barsottini OG; Kawarai T; Orlacchio A
    Brain; 2016 Jan; 139(Pt 1):73-85. PubMed ID: 26556829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MFN2 point mutations occur in 3.4% of Charcot-Marie-Tooth families. An investigation of 232 Norwegian CMT families.
    Braathen GJ; Sand JC; Lobato A; Høyer H; Russell MB
    BMC Med Genet; 2010 Mar; 11():48. PubMed ID: 20350294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mutations in the mitofusin 2 gene are the most common cause of Charcot-Marie-Tooth type 2 disease].
    Sołtysińska E; Kabzińska D; Kochański A
    Neurol Neurochir Pol; 2007; 41(4):350-4. PubMed ID: 17874344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exome sequencing identified a novel de novo OPA1 mutation in a consanguineous family presenting with optic atrophy.
    Cohen L; Tzur S; Goldenberg-Cohen N; Bormans C; Behar DM; Reinstein E
    Genet Res (Camb); 2016 Jun; 98():e10. PubMed ID: 27265430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experience in molecular diagnostic in hereditary neuropathies in a pediatric tertiary hospital].
    Fernández-Ramos JA; López-Laso E; Camino-León R; Gascón-Jiménez FJ; Jiménez-González MD
    Rev Neurol; 2015 Dec; 61(11):490-8. PubMed ID: 26602803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.